5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Increases Myocardial Glucose Uptake during Reperfusion and Induces Late Pre-conditioning: Potential Role of AMP-Activated Protein Kinase

被引:13
|
作者
Kristiansen, Steen B. [1 ]
Solskov, Lasse [2 ]
Jessen, Niels [2 ]
Lofgren, Bo [1 ]
Schmitz, Ole [2 ,3 ]
Nielsen-Kudsk, Jens Erik [1 ]
Nielsen, Torsten T. [1 ]
Botker, Hans Erik [1 ]
Lund, Sten [2 ]
机构
[1] Skejby Sygehus, Dept Cardiol, Aarhus Univ Hosp, DK-8200 Aarhus N, Denmark
[2] Aarhus Sygehus, Aarhus Univ Hosp, Med Res Lab, Med Dept Endocrinol & Diabet M, Aarhus, Denmark
[3] Univ Aarhus, Dept Clin Pharmacol, DK-8000 Aarhus C, Denmark
基金
英国医学研究理事会;
关键词
PHYSICAL-ACTIVITY; LATE-PHASE; RAT; HOMEOSTASIS; ACADESINE; ISCHEMIA; HEART; TRANSLOCATION; GLYCOLYSIS; ADENOSINE;
D O I
10.1111/j.1742-7843.2009.00402.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Late pre-conditioning protects against myocardial ischaemic-reperfusion injury. AMP-activated protein kinase (AMPK) is activated by exercise and 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR). Early pre-conditioning involves AMPK activation and increased myocardial glucose uptake. The aim of the present study was to determine whether AICAR activates myocardial AMPK and induces late pre-conditioning and whether myocardial glucose uptake during reperfusion was modulated. Twenty-four hours after AICAR treatment or exercise, Wistar rats were subjected to ischaemia and reperfusion in a Langendorff model and compared to control rats. AMPK activity increased immediately 2.5-fold in AICAR-treated animals (P < 0.01) and twofold in exercised animals (P < 0.05). AICAR and exercise reduced infarct size by 60% and 50% (both P < 0.01), respectively, and increased myocardial glucose uptake during reperfusion (AICAR; 45%, P < 0.05, exercise; 40%, P < 0.05). In conclusion, AICAR induces late pre-conditioning and increases myocardial glucose uptake during reperfusion in rat hearts. AICAR and exercise activate AMPK, suggesting a role of AMPK in the signalling mechanisms behind late pre-conditioning.
引用
收藏
页码:10 / 16
页数:7
相关论文
共 45 条
  • [1] Activation of AMP-Activated Protein Kinase by 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in the Muscle Microcirculation Increases Nitric Oxide Synthesis and Microvascular Perfusion
    Bradley, Eloise A.
    Eringa, Etto C.
    Stehouwer, Coen D. A.
    Korstjens, Iolente
    Amerongen, Geerten P. van Nieuw
    Musters, Rene
    Sipkema, Pieter
    Clark, Michael G.
    Rattigan, Stephen
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (06) : 1137 - 1142
  • [2] 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase
    Rattan, R
    Giri, S
    Singh, AK
    Singh, I
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (47) : 39582 - 39593
  • [3] 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation
    Guigas, B
    Bertrand, L
    Taleux, N
    Foretz, M
    Wiernsperger, N
    Vertommen, D
    Andreelli, F
    Viollet, B
    Hue, L
    DIABETES, 2006, 55 (04) : 865 - 874
  • [4] Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
    Saha, AK
    Schwarsin, AJ
    Roduit, R
    Massé, F
    Kaushik, V
    Tornheim, K
    Prentki, M
    Ruderman, NB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) : 24279 - 24283
  • [5] 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside inhibits proinflammatory response in glial cells:: A possible role of AMP-activated protein kinase
    Giri, S
    Nath, N
    Smith, B
    Viollet, B
    Singh, AK
    Singh, I
    JOURNAL OF NEUROSCIENCE, 2004, 24 (02): : 479 - 487
  • [6] Inhibition of hepatic phosphatidylcholine synthesis by 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside is independent of AMP-activated protein kinase activation
    Jacobs, Rene L.
    Lingrell, Susanne
    Dyck, Jason R. B.
    Vance, Dennis E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (07) : 4516 - 4523
  • [7] Knockout of the α2 but not α1 5′-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside- but not contraction-induced glucose uptake in skeletal muscle
    Jorgensen, SB
    Viollet, B
    Andreelli, F
    Frosig, C
    Birk, JB
    Schjerling, P
    Vaulont, S
    Richter, EA
    Wojtaszewski, JFP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) : 1070 - 1079
  • [8] Loss of the Anorexic Response to Systemic 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside Administration Despite Reducing Hypothalamic AMP-Activated Protein Kinase Phosphorylation in Insulin-Deficient Rats
    Vitzel, Kaio F.
    Bikopoulos, George
    Hung, Steven
    Curi, Rui
    Ceddia, Rolando B.
    PLOS ONE, 2013, 8 (08):
  • [9] Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside
    Eloise A Bradley
    Lei Zhang
    Amanda J Genders
    Stephen M Richards
    Stephen Rattigan
    Michelle A Keske
    Cardiovascular Diabetology, 14
  • [10] Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
    Bradley, Eloise A.
    Zhang, Lei
    Genders, Amanda J.
    Richards, Stephen M.
    Rattigan, Stephen
    Keske, Michelle A.
    CARDIOVASCULAR DIABETOLOGY, 2015, 14